First Commonwealth Financial Corp Johnson & Johnson Transaction History

First Commonwealth Financial Corp

$396 Million
Q1 2025

A detailed history of First Commonwealth Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, First Commonwealth Financial Corp holds 11,711 shares of JNJ stock, worth $1.95 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

11,711

Previous 9,922 18.03%

Holding current value

$1.95 Million

Previous $1.43 Million 35.43%

% of portfolio

0.49%

Previous 0.36%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$142.06 - $167.7 $254,145 - $300,015	1,789 Added 18.03%	11,711 $1.94 Million
Q4 2024 Feb 13, 2025	BUY	$143.34 - $165.86 $171,721 - $198,700	1,198 Added 13.73%	9,922 $1.43 Million
Q3 2024 Nov 13, 2024	SELL	$145.48 - $167.38 $18,330 - $21,089	-126 Reduced 1.42%	8,724 $1.41 Million
Q2 2024 Aug 13, 2024	BUY	$144.38 - $157.78 $135,572 - $148,155	939 Added 11.87%	8,850 $1.29 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $81,956 - $85,926	-528 Reduced 6.26%	7,911 $1.25 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $111,675 - $121,860	-767 Reduced 8.33%	8,439 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $8,722 - $9,770	56 Added 0.61%	9,206 $1.43 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $133,358 - $143,519	864 Added 10.43%	9,150 $1.51 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $16,011 - $19,107	-106 Reduced 1.26%	8,286 $1.28 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $37,486 - $42,070	234 Added 2.87%	8,392 $1.48 Million
Q3 2022 Nov 09, 2022	BUY	$161.33 - $179.52 $15,165 - $16,874	94 Added 1.17%	8,158 $1.33 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $34,815 - $38,504	-207 Reduced 2.5%	8,064 $1.43 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $52,976 - $60,162	-335 Reduced 3.89%	8,271 $1.47 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $322,463 - $357,784	-2,068 Reduced 19.37%	8,606 $1.47 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $77,035 - $85,607	-477 Reduced 4.28%	10,674 $1.72 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $74,317 - $79,718	466 Added 4.36%	11,151 $1.84 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $147,406 - $164,172	-963 Reduced 8.27%	10,685 $1.76 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $273,945 - $314,445	-1,998 Reduced 14.64%	11,648 $1.83 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $22,320 - $24,458	159 Added 1.18%	13,646 $2.03 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $70,845 - $85,530	550 Added 4.25%	13,487 $1.9 Million
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $289,186 - $400,681	2,602 Added 25.18%	12,937 $1.7 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $44,752 - $51,400	-351 Reduced 3.28%	10,335 $1.51 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $173,413 - $194,163	1,366 Added 14.66%	10,686 $1.38 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $40,263 - $44,281	-307 Reduced 3.19%	9,320 $1.3 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $43,121 - $47,947	-343 Reduced 3.44%	9,627 $1.35 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $37,834 - $45,534	308 Added 3.19%	9,970 $1.29 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $108,449 - $127,448	-892 Reduced 8.45%	9,662 $1.34 Million
Q2 2018 Aug 13, 2018	SELL	$119.4 - $131.76 $127,519 - $140,719	-1,068 Reduced 9.19%	10,554 $1.28 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $101,080 - $119,697	808 Added 7.47%	11,622 $1.49 Million
Q4 2017 Feb 15, 2018	BUY	$131.22 - $143.62 $230,684 - $252,483	1,758 Added 19.41%	10,814 $1.51 Million
Q3 2017 Nov 13, 2017	SELL	$129.47 - $135.38 $137,885 - $144,179	-1,065 Reduced 10.52%	9,056 $1.18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,121	10,121 $1.34 Million

Others Institutions Holding JNJ

# of Institutions

4,635

Shares Held

1.73B

Call Options Held

25.1M

Put Options Held

15.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $435B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Commonwealth Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Commonwealth Financial Corp with notifications on news.

Account

First Commonwealth Financial Corp Johnson & Johnson Transaction History